국가임상시험지원재단

페이스북 유튜브

유관기관 바로가기

유관기관 바로가기

정부/공공기관: 보건복지부; 식품의약품안전처; 질병관리청; 국민건강보험공단; 한국보건산업진흥원; 건강보험심사평가원; 국립보건연구원; 국립암센터; 식품의약품안전평가원; 한국보건의료정보원; 국세청; 한국보건복지인재원; 한국의약품안전관리원; 한국보건의료연구원; 오송첨단의료산업진흥재단; 대구경북첨단의료산업진흥재단; 재단법인 국가생명윤리정책원

임상시험센터: CHA 의과대학교 분당차병원; 가천대길병원; 가톨릭대학교 서울성모병원; 강남세브란스병원; 강동경희대학교병원; 건국대학교병원; 경북대학교병원; 경희대학교병원; 고려대학교 의과대학 부속 구로병원; 고려대학교안암병원; 동국대학교일산불교병원; 동아대학교병원; 베스티안병원; 부산대학교병원; 분당서울대학교병원; 삼성서울병원; 서울대학교병원; 서울아산병원; 세브란스병원; 아주대학교병원; 양지병원; 원광대학교병원; 김포우리병원

이화여자대학교 의과대학 부속 목동병원

인제대학교 부산백병원

인하대학교 의과대학부속병원

전남대학교병원

전북대학교병원

중앙대학교광명병원

충남대학교병원

충북대학교병원

울산대학교병원

한림대학교성심병원

한양대학교병원

원주세브란스기독병원

양산부산대학교병원

한국의약연구소

㈜엘에스케이글로벌파마서비스

㈜메디칼리써치

㈜프라임코어컨설팅

씨알에스큐브

㈜해밀턴씨에스

인바이츠바이오코아㈜

대한항암요법연구회

㈜디티앤사노메딕스

㈜아리바이오에이치앤비

㈜휴먼피부임상시험센터

㈜이피에스인터내셔널코리아

㈜지아이비타

㈜엠바이오

인투인월드

㈜리서치멘토

위키씨알오

주식회사 세이프소프트

㈜에버트라이

㈜셀타스퀘어

주식회사 아리비앤씨

스페로 주식회사

㈜지알케이파트너스

㈜에비드넷

주식회사 더웨이헬스케어

㈜메디플렉서스

㈜드림씨아이에스

주식회사리니칼코리아

주식회사 컨설팅바로

클리니젠코리아 유한회사

(주)비엑스플랜트

주식회사 제이앤피메디

주식회사 미라클러스

벡코씨알오 주식회사

㈜시믹코리아

주식회사 카카오헬스케어

분석CRO/센트럴랩: ㈜프로메디스; GCCL; SCL헬스케어; SML메디트리; 케일럽 멀티랩; (주)바이오메디앙; (주)디티앤씨알오; 인바이츠바이오코아㈜; ㈜엠바이오; ㈜마크로젠; ㈜리서치멘토; ㈜이원생명과학연구원; 휴사이언스; 넥시오랩; 뉴로핏 주식회사; 이원의료재단; 의료법인 유투의료재단; 주식회사 프라임헬스케어

유관기관/협회: 국가신약개발재단; (사)한국임상CRO협회; 대한CRC협의회(KACRC); 대한기관윤리심의기구협의회; 대한임상시험센터협의회(KACTC); 한국글로벌의약산업협회; 한국바이오의약품협회; 한국바이오협회; 한국신약개발연구조합; 한국제약바이오협회; 재생의료진흥재단; 한국규제과학센터; 한국병원약사회; 사단법인 한국에프디시규제과학회

학회/학교: 대한간학회; 대한감염학회; 대한암학회; 대한의학회; 대한임상약리학회; 대한항암요법연구회; 아주대학교 제약임상대학원; 한국임상개발연구회; 한국제약의학회; 대한소아혈액종양학회

정보서비스: 의약품통합정보시스템
(식품의약품안전처); 국가건강정보포털
(질병관리청); 임상연구정보서비스
(질병관리청); 의료기기정보포털
(식품의약품안전처); 제약산업정보포털
(한국보건산업진흥원); 희귀질환헬프라인
(질병관리청); 임상진료지침정보센터
(대한의학회)

해외 유관 기관: 정부 규제기관; (미국) FDA(U.S. Food & Drug Administration); (중국) NMPA(National Medical Products Administration); (유럽) EMA(European Medicines Agency); (영국) MHRA(Medicines & Healthcare products Regulatory Agency); (캐나다) Health Canada; (호주) TGA(Therapeutic Goods Administration); (인도) CDSCO(Central Drugs Standard Control Organization); (일본) MHLW(Ministry of Health, Labour, and Welfare); (일본) PMDA(Pharmaceuticals & Medical Devices Agency); (싱가폴) HSA(Health Sciences Authority); (대만) TFDA(Taiwan Food and Drug Administration); (홍콩) DO(Drug Office); (태국) FDA Thailand; (베트남) DAV(Drug Administration of Vietnam); (인도네시아) NA-DFC(Indonesia National Agency of Drug and Food Control); (인도네시아) BPOM(Badan Pengawas Obat dan Makanan)

지원 기관

(미국) ACRES(Alliance for Clinical Research Excellence and Safety)

(미국) AARHPP(Association for the Accreditation of Human Research Protection Program)

(미국) ACRP(Association of Clinical Research Professionals)

(미국) CenterWatch

(미국) DIA(Drug Information Association)

(미국) NIH(National Institutes of Health)

(미국) NCI(National Cancer Institute)

(미국) MIT CRITICAL DATA

(미국) TransCelerate

(유럽) ECRIN(European Clinical Research Infrastructure Network)

(영국) UKCRC(UK Clinical Research Collaboration)

(영국) NIHR(National Institute for Health Research)

(호주) Australian Clinical Trials

(일본) TRI(Translational Research Informatics Center)

(일본) AMED(Japan Agency for Medical Research and Development)

(싱가폴) SCRI(Singapore Clinical Research Institute)

(네덜란드) IFAPP(International Federation of Associations of Pharmaceutical Physicians)

(사우디아라비아) KAIMRC(King Abdullah International Medical Research Center)

정부/공공기관: 보건복지부; 식품의약품안전처; 질병관리청; 국민건강보험; 한국보건산업진흥원; 건강보험심사평가원; 국립보건연구원; 국립암센터; 식품의약품안전평가원; 한국보건의료정보원; 국세청; 한국보건복지인재원; 한국의약품안전관리원; 한국보건의료연구원; 오송첨단의료산업진흥재단; 대구경북첨단의료산업진흥재단; 재단법인 국가생명윤리정책원

임상시험센터: CHA 의과대학교 분당차병원; 가천대길병원; 가톨릭대학교 서울성모병원; 강남세브란스병원; 강동경희대학교병원; 건국대학교병원; 경북대학교병원; 경희대학교병원; 고려대학교 의과대학 부속 구로병원; 고려대학교안암병원; 동국대학교일산불교병원; 동아대학교병원; 베스티안병원; 부산대학교병원; 분당서울대학교병원; 삼성서울병원; 서울대학교병원; 서울아산병원; 세브란스병원; 아주대학교병원; 양지병원; 원광대학교병원; 이화여자대학교의과대학부속목동병원; 인제대학교 부산백병원; 인하대학교 의과대학부속병원; 전남대학교병원; 전북대학교병원; 중앙대학교광명병원; 충남대학교병원; 충북대학교병원; 울산대학교병원; 한림대학교성심병원; 한양대학교병원; 부민병원; 원주세브란스기독병원; 양산부산대학교병원

CRO: ㈜코랩; ㈜프로메디스; ㈜프리모생명과학; KH메디케어; 디투에스; 메디칼엑셀런스; 베데스다소프트; 사이넥스; 사이클룩스; 서울CRO; 심유; 씨씨앤아이리서치; ㈜씨엔알리서치; 알엔디모티브; 현대에이디엠코리아(주); 올리브헬스케어; 움트; ㈜메디헬프라인; ㈜엘에스케이글로벌파마서비스; 케일럽 멀티랩; 클립스비엔씨㈜; 파마크로; (주)헬프트라이알; 클루피주식회사; 네오뉴트라; 스누빛; 한국의약연구소; 굳빙센터; ㈜엘에스케이글로벌파마서비스; ㈜메디팁; ㈜메디칼리써치; ㈜프라임코어컨설팅; 씨알에스큐브; ㈜해밀턴씨에스; 인바이츠바이오코아㈜; 대한항암요법연구회; ㈜디티앤사노메딕스; ㈜아리바이오에이치앤비; ㈜휴먼피부임상시험센터; ㈜이피에스인터내셔널코리아; ㈜지아이비타; ㈜엠바이오; 인투인월드; ㈜리서치멘토; ㈜드림씨아이에스; 주식회사리니칼코리아; 주식회사 컨설팅바로; 클리니젠코리아 유한회사; (주)비엑스플랜트; 주식회사 제이앤피메디; 주식회사 미라클러스; 벡코씨알오 주식회사; ㈜시믹코리아; 주식회사 카카오헬스케어

분석CRO/센트럴랩: ㈜프로메디스; GCCL; SCL헬스케어; SML메디트리; 케일럽 멀티랩; (주)바이오메디앙; (주)디티앤씨알오; 인바이츠바이오코아㈜; ㈜엠바이오; ㈜마크로젠; ㈜리서치멘토; 넥시오랩; 뉴로핏 주식회사; 이원의료재단; 의료법인 유투의료재단; 주식회사 프라임헬스케어

유관기관/협회: 국가신약개발재단; (사)한국임상CRO협회; 대한CRC협의회(KACRC); 대한기관윤리심의기구협의회; 대한임상시험센터협의회(KACTC); 한국글로벌의약산업협회; 한국바이오의약품협회; 한국바이오협회; 한국신약개발연구조합; 한국제약바이오협회; 재생의료진흥재단; 한국규제과학센터; 한국병원약사회; 사단법인 한국에프디시규제과학회

학회/학교: 대한간학회; 대한감염학회; 대한암학회; 대한의학회; 대한임상약리학회; 대한항암요법연구회; 아주대학교 제약임상대학원; 한국임상개발연구회; 한국제약의학회; 대한소아혈액종양학회

정보서비스: 의약품통합정보시스템(식품의약품안전처); 국가건강정보포털(질병관리청); 임상연구정보서비스(질병관리청); 의료기기정보포털(식품의약품안전처); 제약산업정보포털(한국보건산업진흥원); 희귀질환헬프라인(질병관리청); 임상진료지침정보센터(대한의학회)

해외 유관 기관: 정부 규제기관; (미국) FDA(U.S. Food & Drug Administration); (중국) NMPA(National Medical Products Administration); (유럽) EMA(European Medicines Agency); (영국) MHRA(Medicines & Healthcare products Regulatory Agency); (캐나다) Health Canada; (호주) TGA(Therapeutic Goods Administration); (인도) CDSCO(Central Drugs Standard Control Organization); (일본) MHLW(Ministry of Health, Labour, and Welfare); (일본) PMDA(Pharmaceuticals & Medical Devices Agency); (싱가폴) HSA(Health Sciences Authority); (대만) TFDA(Taiwan Food and Drug Administration); (홍콩) DO(Drug Office); (태국) FDA Thailand; (베트남) DAV(Drug Administration of Vietnam); (인도네시아) NA-DFC(Indonesia National Agency of Drug and Food Control); (인도네시아) BPOM(Badan Pengawas Obat dan Makanan); 지원 기관; (미국) ACRES(Alliance for Clinical Research Excellence and Safety); (미국) AARHPP(Association for the Accreditation of Human Research Protection Program); (미국) ACRP(Association of Clinical Research Professionals); (미국) CenterWatch; (미국) DIA(Drug Information Association); (미국) NIH(National Institutes of Health); (미국) NCI(National Cancer Institute); (미국) MIT CRITICAL DATA; (미국) TransCelerate; (유럽) ECRIN(European Clinical Research Infrastructure Network); (영국) UKCRC(UK Clinical Research Collaboration); (영국) NIHR(National Institute for Health Research); (호주) Australian Clinical Trials; (일본) TRI(Translational Research Informatics Center); (일본) AMED(Japan Agency for Medical Research and Development); (싱가폴) SCRI(Singapore Clinical Research Institute); (네덜란드) IFAPP(International Federation of Associations of Pharmaceutical Physicians); (사우디아라비아) KAIMRC(King Abdullah International Medical Research Center)

* CRO 게재 기준: CRO자율등록 기관

ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.

전체 2550건이 검색되었습니다.


No.	Status	Study Title	Conditions	Interventions	Phase	Sponsor/Collaborators	Funder Type	Number Enrolled	Sex	Age	Locations
884	Withdrawn	Phase IIb Clinical Trial of Recombinant Novel Coronavirus Pneumonia (COVID-19) Vaccine (Sf9 Cells)	COVID-19	Biological: Recombinant COVID-19 vaccine (Sf9 cells) Biological: Placebo	Phase 2	Jiangsu Province Centers for Disease Control and Prevention, West China Hospital	NETWORK	0	All	18 Years ~ 85 Years	Jiangsu Provincial Center for Diseases Control and Prevention, Nanjing, Jiangsu, China
883	Recruiting	Phase IIb Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) (Ad5-nCoV) in Adults 18 Years of Age and Older.	Covid19	Biological: Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) (Ad5-nCoV)	Phase 2	Fundacion Huesped, Canadian Center for Vaccinology, CanSino Biologics Inc., Hospital Fernandez	OTHER	876	All	18 Years	Fundacion Huesped, Caba, Buenos Aires, Argentina Centro de Estudio Infectologicos (CEI), Capital Federal, Buenos Aires, Argentina Helios Salud, Capital Federal, Buenos Aires, Argentina Hospital Fernandez, Capital Federal, Buenos Aires, Argentina
882	Active, not recruiting	Phase III Clinical Trial of CinnaGen COVID-19 Vaccine (SpikoGen)	Covid19	Biological: SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant Biological: Saline placebo	Phase 3	Cinnagen, Vaxine Pty Ltd	INDUSTRY	16876	All	18 Years ~ 50 Years	Espinas Palace Hotel, Tehran, Iran, Islamic Republic of
881	Recruiting	Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study	COVID-19	Drug: DAS181 Drug: Placebo Drug: DAS181 COVID-19 Drug: DAS181 OL	Phase 3	Ansun Biopharma, Inc.	INDUSTRY	274	All		City of Hope cancer Center, Duarte, California, United States UCLA, Los Angeles, California, United States University of California Davis Health System, Sacramento, California, United States University of California San Diego Medical Center, San Diego, California, United States Children's Hospital Colorado, Aurora, Colorado, United States Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States University of Chicago, Chicago, Illinois, United States Loyola University Medical Center, Maywood, Illinois, United States University of Kansas Medical Center, Fairway, Kansas, United States Louisiana State University, Shreveport, Louisiana, United States University of Maryland, Baltimore, Maryland, United States The Johns Hopkins Hospital, Baltimore, Maryland, United States Brigham and Women's Hospital, Boston, Massachusetts, United States Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States Universtiy of Michigan, Ann Arbor, Michigan, United States Washington University, Saint Louis, Missouri, United States University of Nebraska Medical Center, Omaha, Nebraska, United States Memorial Sloan Kettering Cancer Center, New York, New York, United States Weill Cornell Medical College, New York, New York, United States Duke University, Durham, North Carolina, United States Novant Health, Winston-Salem, North Carolina, United States The Lindner Center- The Christ Hospital, Cincinnati, Ohio, United States Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States University of Cincinnati, Cincinnati, Ohio, United States The Cleveland Clinic Foundation, Cleveland, Ohio, United States St. Elizabeth Youngstown Hospital, Youngstown, Ohio, United States Oregon Health & Science University, Portland, Oregon, United States University of Pennsylvania, Philadelphia, Pennsylvania, United States University of Pittsburgh Medical Center Health System, Pittsburgh, Pennsylvania, United States Kent Hospital, Warwick, Rhode Island, United States Vanderbilt University Medical Center, Nashville, Tennessee, United States Cook Children's, Fort Worth, Texas, United States Texas Health, Fort Worth, Texas, United States Therapeutic Concepts, Houston, Texas, United States MD Anderson, Houston, Texas, United States VCU Health System, Richmond, Virginia, United States Seattle Children's Hospital, Seattle, Washington, United States Fred Hutchinson Cancer Research Center, Seattle, Washington, United States Medical College of Wisconsin, Milwaukee, Wisconsin, United States Froedtert Medical College Pulmonary Clinic, Milwaukee, Wisconsin, United States Westmead Hospital, Sydney, New South Wales, Australia The Wesley Hospital, Auchenflower, Queensland, Australia Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia Royal Melbourne Hospital, Melbourne, Victoria, Australia Shanghai Pulmonary Hospital, Yangpu, Shanghai, China West China Hospital, Chengdu, Sichuan, China Shulan (Hangzhou) Hospital co., LTD, Hangzhou, Zhejiang, China The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China Rigshospitalet, Copenhagen, Denmark Hopital Henri Mondor, Creteil, Ile-de-France, France Prince of Wales Hospital, Sha Tin, New Territories, Hong Kong Samsung Medical Center, Gangnam-gu, Seoul, Gyeonggi-do, Korea, Republic of Seoul National University Hospital, Jongno-gu, Seoul, Gyeonggi-do, Korea, Republic of The Catholic University of Korea, Seoul St. Mary's Hospital, Seocho-gu, Seoul, Gyeonggi-do, Korea, Republic of Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, Korea, Republic of Asan Medical Center, Songpa-gu, Seoul, Gyeonggi-do, Korea, Republic of National Cheng Kung University Hospital, North District, Tainan, Taiwan National Taiwan University Hospital, Zhongzheng, Taipei City, Taiwan
880	Active, not recruiting	Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults	SARS-CoV-2	Biological: AZD1222 Biological: Placebo	Phase 3	AstraZeneca, Iqvia Pty Ltd	INDUSTRY	32459	All	18 Years ~ 130 Years	Research Site, Phoenix, Arizona, United States Research Site, Scottsdale, Arizona, United States Research Site, Little Rock, Arkansas, United States Research Site, Berkeley, California, United States Research Site, El Centro, California, United States Research Site, Los Angeles, California, United States Research Site, Los Angeles, California, United States Research Site, San Diego, California, United States Research Site, San Diego, California, United States Research Site, San Francisco, California, United States Research Site, San Francisco, California, United States Research Site, Torrance, California, United States Research Site, Denver, Colorado, United States Research Site, Danbury, Connecticut, United States Research Site, Atlantis, Florida, United States Research Site, Coral Gables, Florida, United States Research Site, Miami Lakes, Florida, United States Research Site, Orlando, Florida, United States Research Site, Stockbridge, Georgia, United States Research Site, Honolulu, Hawaii, United States Research Site, Meridian, Idaho, United States Research Site, Chicago, Illinois, United States Research Site, Indianapolis, Indiana, United States Research Site, Ankeny, Iowa, United States Research Site, Fairway, Kansas, United States Research Site, Kansas City, Kansas, United States Research Site, Wichita, Kansas, United States Research Site, Wichita, Kansas, United States Research Site, Lexington, Kentucky, United States Research Site, Lake Charles, Louisiana, United States Research Site, Monroe, Louisiana, United States Research Site, Baltimore, Maryland, United States Research Site, Baltimore, Maryland, United States Research Site, Bethesda, Maryland, United States Research Site, Boston, Massachusetts, United States Research Site, Boston, Massachusetts, United States Research Site, Ann Arbor, Michigan, United States Research Site, Royal Oak, Michigan, United States Research Site, Bloomington, Minnesota, United States Research Site, Gulfport, Mississippi, United States Research Site, Butte, Montana, United States Research Site, Henderson, Nevada, United States Research Site, Portsmouth, New Hampshire, United States Research Site, Berlin, New Jersey, United States Research Site, Albuquerque, New Mexico, United States Research Site, Bronx, New York, United States Research Site, Brooklyn, New York, United States Research Site, Mineola, New York, United States Research Site, New York, New York, United States Research Site, New York, New York, United States Research Site, New York, New York, United States Research Site, Rochester, New York, United States Research Site, Rochester, New York, United States Research Site, Valhalla, New York, United States Research Site, Durham, North Carolina, United States Research Site, Fargo, North Dakota, United States Research Site, Cincinnati, Ohio, United States Research Site, Columbus, Ohio, United States Research Site, Columbus, Ohio, United States Research Site, Yukon, Oklahoma, United States Research Site, Portland, Oregon, United States Research Site, Pittsburgh, Pennsylvania, United States Research Site, Warwick, Rhode Island, United States Research Site, Charleston, South Carolina, United States Research Site, Charleston, South Carolina, United States Research Site, Spartanburg, South Carolina, United States Research Site, Knoxville, Tennessee, United States Research Site, Nashville, Tennessee, United States Research Site, Austin, Texas, United States Research Site, Dallas, Texas, United States Research Site, Houston, Texas, United States Research Site, McAllen, Texas, United States Research Site, San Antonio, Texas, United States Research Site, San Antonio, Texas, United States Research Site, The Woodlands, Texas, United States Research Site, West Jordan, Utah, United States Research Site, Burlington, Vermont, United States Research Site, Fort Belvoir, Virginia, United States Research Site, Richmond, Virginia, United States Research Site, Seattle, Washington, United States Research Site, Seattle, Washington, United States Research Site, South Charleston, West Virginia, United States Research Site, Madison, Wisconsin, United States Research Site, Caba, Argentina Research Site, Ciudad Autonoma de Bs. As., Argentina Research Site, Ciudad Autonoma de Buenos Aire, Argentina Research Site, Quillota, Chile Research Site, Region Metropolitana, Chile Research Site, Santiago, Chile Research Site, Santiago, Chile Research Site, Barranquilla, Colombia Research Site, Bogota, Colombia Research Site, Floridablanca, Colombia Research Site, Manizales, Colombia Research Site, Medellin, Colombia Research Site, Callao, Peru Research Site, Cercado De Lima, Peru Research Site, Cercardo De Lima, Peru Research Site, Lima, Peru Research Site, Lima, Peru Research Site, Lima, Peru Research Site, Lima, Peru Research Site, Lima, Peru Research Site, Lima, Peru Research Site, Lima, Peru
879	Active, not recruiting	Phase III Double-blind, Placebo-controlled Study of AZD7442 for Post- Exposure Prophylaxis of COVID-19 in Adults	COVID-19	Drug: AZD7442 Drug: Placebo	Phase 3	AstraZeneca, Iqvia Pty Ltd	INDUSTRY	1121	All	18 Years ~ 120 Years	Research Site, Guntersville, Alabama, United States Research Site, Tempe, Arizona, United States Research Site, Little Rock, Arkansas, United States Research Site, Bakersfield, California, United States Research Site, Corona, California, United States Research Site, Garden Grove, California, United States Research Site, Huntington Beach, California, United States Research Site, Huntington Park, California, United States Research Site, Modesto, California, United States Research Site, Coral Springs, Florida, United States Research Site, Miami Lakes, Florida, United States Research Site, Miami Lakes, Florida, United States Research Site, Miami Springs, Florida, United States Research Site, Miami, Florida, United States Research Site, Miami, Florida, United States Research Site, Miami, Florida, United States Research Site, Miami, Florida, United States Research Site, Miami, Florida, United States Research Site, Mount Dora, Florida, United States Research Site, North Miami, Florida, United States Research Site, Pembroke Pines, Florida, United States Research Site, Pompano Beach, Florida, United States Research Site, Tampa, Florida, United States Research Site, West Palm Beach, Florida, United States Research Site, Atlanta, Georgia, United States Research Site, Buford, Georgia, United States Research Site, Conyers, Georgia, United States Research Site, Chicago, Illinois, United States Research Site, Chicago, Illinois, United States Research Site, Hazel Crest, Illinois, United States Research Site, Noblesville, Indiana, United States Research Site, West Des Moines, Iowa, United States Research Site, Wichita, Kansas, United States Research Site, Owensboro, Kentucky, United States Research Site, Bethesda, Maryland, United States Research Site, High Point, North Carolina, United States Research Site, Wilmington, North Carolina, United States Research Site, Orangeburg, South Carolina, United States Research Site, Dallas, Texas, United States Research Site, El Paso, Texas, United States Research Site, Friendswood, Texas, United States Research Site, Gonzales, Texas, United States Research Site, Harlingen, Texas, United States Research Site, Houston, Texas, United States Research Site, San Antonio, Texas, United States Research Site, Riverton, Utah, United States Research Site, Alexandria, Virginia, United States Research Site, Portsmouth, Virginia, United States Research Site, Richmond, Virginia, United States Research Site, Tacoma, Washington, United States Research Site, Bournemouth, United Kingdom Research Site, Hayle, United Kingdom Research Site, London, United Kingdom Research Site, London, United Kingdom Research Site, London, United Kingdom Research Site, Manchester, United Kingdom Research Site, Southampton, United Kingdom
878	Active, not recruiting	Phase III Double-blind, Placebo-controlled Study of AZD7442 for Pre-exposure Prophylaxis of COVID-19 in Adult.	COVID-19	Drug: AZD7442 Drug: Placebo	Phase 3	AstraZeneca, Iqvia Pty Ltd	INDUSTRY	5197	All	18 Years ~ 120 Years	Research Site, Birmingham, Alabama, United States Research Site, Tempe, Arizona, United States Research Site, Little Rock, Arkansas, United States Research Site, Cerritos, California, United States Research Site, Fresno, California, United States Research Site, Garden Grove, California, United States Research Site, Huntington Beach, California, United States Research Site, Lancaster, California, United States Research Site, Modesto, California, United States Research Site, Victorville, California, United States Research Site, Westminster, California, United States Research Site, Hartford, Connecticut, United States Research Site, Middlebury, Connecticut, United States Research Site, Clearwater, Florida, United States Research Site, Coral Springs, Florida, United States Research Site, Hollywood, Florida, United States Research Site, Lauderdale Lakes, Florida, United States Research Site, Miami, Florida, United States Research Site, Ormond Beach, Florida, United States Research Site, Pompano Beach, Florida, United States Research Site, Wesley Chapel, Florida, United States Research Site, West Palm Beach, Florida, United States Research Site, Atlanta, Georgia, United States Research Site, Columbus, Georgia, United States Research Site, Conyers, Georgia, United States Research Site, Chicago, Illinois, United States Research Site, Hazel Crest, Illinois, United States Research Site, Quincy, Illinois, United States Research Site, Evansville, Indiana, United States Research Site, Noblesville, Indiana, United States Research Site, Wichita, Kansas, United States Research Site, Wichita, Kansas, United States Research Site, Minneapolis, Minnesota, United States Research Site, Minneapolis, Minnesota, United States Research Site, Saint Louis, Missouri, United States Research Site, Omaha, Nebraska, United States Research Site, Las Vegas, Nevada, United States Research Site, Albuquerque, New Mexico, United States Research Site, Bronx, New York, United States Research Site, Jamaica, New York, United States Research Site, Ridgewood, New York, United States Research Site, Greensboro, North Carolina, United States Research Site, Columbus, Ohio, United States Research Site, Oklahoma City, Oklahoma, United States Research Site, Summerville, South Carolina, United States Research Site, Rapid City, South Dakota, United States Research Site, Austin, Texas, United States Research Site, El Paso, Texas, United States Research Site, El Paso, Texas, United States Research Site, Houston, Texas, United States Research Site, San Antonio, Texas, United States Research Site, San Antonio, Texas, United States Research Site, Shenandoah, Texas, United States Research Site, Sugar Land, Texas, United States Research Site, Layton, Utah, United States Research Site, Alexandria, Virginia, United States Research Site, Chesapeake, Virginia, United States Research Site, Alken, Belgium Research Site, Bruxelles, Belgium Research Site, Gozee, Belgium Research Site, Namur, Belgium Research Site, Wetteren, Belgium Research Site, Clermont-Ferrand cedex, France Research Site, Dijon cedex, France Research Site, La Roche S/ Yon Cedex 9, France Research Site, Lille, France Research Site, Limoges cedex, France Research Site, Nantes Cedex 1, France Research Site, Paris cedex 10, France Research Site, Paris cedex 14, France Research Site, Saint Etienne Cedex 2, France Research Site, Tours cedex 9, France Research Site, Barcelona, Spain Research Site, Madrid, Spain Research Site, Madrid, Spain Research Site, Marbella (Malaga), Spain Research Site, Pozuelo de Alarcon, Spain Research Site, Bournemouth, United Kingdom Research Site, Enfield, United Kingdom Research Site, Hayle, United Kingdom Research Site, London, United Kingdom Research Site, Preston, United Kingdom Research Site, Rochdale, United Kingdom Research Site, Salford, United Kingdom Research Site, Torpoint, United Kingdom Research Site, Wakefield, United Kingdom